Table 2.

Proteomic analysis of PVAT

Protein name	Fold change	p ≤ 0.05
DERPC	−9.59	0.05
Parathymosin	−7.18	0.04
Fibrinogen beta chain precursor	−5.01	0.05
Histone H2B.c (H2B/c) * peptide sequence 1	−4.95	0.02
Fibrinogen gamma chain precursor	−4.63	0.03
Serum albumin precursor	−4.47	0.02
Hemoglobin subunit delta * peptide sequence 1	−4.29	0.03
Annexin A2 isoform 1 * peptide sequence 1	−4.02	0.02
Alpha 2 globin variant * peptide sequence 1	−4.02	0.02
Sorting nexin-13	−3.83	0.05
Annexin A2 isoform 1 * peptide sequence 2	−3.74	0.02
Haptoglobin precursor	−3.12	0.01
Histone H2B.c (H2B/c) * peptide sequence 2	−2.93	0.01
Hemoglobin subunit delta * peptide sequence 2	−2.89	0.05
Protein S100-A6	−2.84	0.02
Lumican precursor	−2.7	0.02
Serum albumin precursor * peptide sequence 1	−2.67	0.02
Serum albumin precursor * peptide sequence 2	−2.47	0.04
Hemoglobin beta chain * peptide sequence 1	−2.47	0.04
Superoxide dismutase	−2.42	0.02
Annexin A2 isoform 1 * peptide sequence 3	−2.42	0.02
Alpha 2 globin variant * peptide sequence 2	−2.42	0.02
Vimentin * peptide sequence 1	−2.37	0.004
Hemoglobin beta chain * peptide sequence 2	−2.24	0.03
Collagen alpha 2(I) chain precursor * peptide sequence 1	−2.2	0.01
Profilin-1 (profilin I)	−2.16	0.03
Peroxiredoxin-1	−2.15	0.05
Collagen alpha 2(I) chain precursor * peptide sequence 2	−2.14	0.03
Ubiquitin	−2.10	0.01
Adiponectin	−2.1	0.02

A negative fold change indicated a lower abundance of the protein in the obese than in the control group.